BIO Medical Applications Of Texas, Inc in Lubbock, Texas - Dialysis Center

BIO Medical Applications Of Texas, Inc is a medicare approved dialysis facility center in Lubbock, Texas and it has 13 dialysis stations. It is located in Lubbock county at 8704 University Ave, Lubbock, TX, 79423. You can reach out to the office of BIO Medical Applications Of Texas, Inc at (806) 748-0002. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Texas, Inc has the following ownership type - Profit. It was first certified by medicare in May, 2017. The medicare id for this facility is 672811 and it accepts patients under medicare ESRD program.

Name	BIO Medical Applications Of Texas, Inc
Location	8704 University Ave, Lubbock, Texas
No. of Dialysis Stations	13
Medicare ID	672811
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	Yes

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with BIO Medical Applications Of Texas, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1235685470
Organization Name	Fresenius Kidney Care Caprock
Doing Business As	Bio-medical Applications Of Texas, Inc.
Address	8704 University Ave Lubbock, Texas, 79423
Phone Number	(806) 748-0002

Dialysis patients with Hemoglobin data

4

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	17
  Adult patient months included in Kt/V greater than or equal to 1.2	57
  Percentage of adult patients getting regular hemodialysis at the center	86
  Percentage of pediatric patients getting regular hemodialysis at the center

• Peritoneal Dialysis

  Adult patients getting regular peritoneal dialysis at the center	28
  Adult patient months included in Kt/V greater than or equal to 1.7	42
  Percentage of adult patients getting regular peritoneal dialysis at the center	81
  Percentage of pediatric patients getting regular peritoneal dialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Texas, Inc with elevated calcium levels.

Patients with hypercalcemia	47
Hypercalcemia patient months	104
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	56
Patients with Serumphosphor less than 3.5 mg/dL	10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	29
Patients with Serumphosphor from 5.6 to 7 mg/dL	27
Patients with Serumphosphor greater than 7 mg/dL	12

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	22
Patient months included in arterial venous fistula and catheter summaries	51
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	61
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	6